与中风后抑郁症和药物治疗相关的机制
1Institute of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Frontiers in neurology
|November 29, 2023
概括
脑卒中后抑郁症 (PSD) 是影响中风幸存者的常见并发症. 研究正在探索超越神经递质的复杂机制和治疗方法,包括神经炎症和神经变因子.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脑卒中后抑郁症 (PSD) 是中风后常见的神经精神疾病并发症,严重影响患者的康复和生活质量.
- 它的潜在机制很复杂,涉及神经递质失衡,神经炎症,神经内分泌学,神经营养因素和病变部位特征.
研究的目的:
- 审查目前对PSD机制的理解.
- 总结PSD的既定和新兴的药理疗法.
- 强调需要进一步研究PSD病因和治疗的必要性.
主要方法:
- 对PSD机制研究的文献综述.
- 对PSD药理干预的临床研究分析.
- 对PSD治疗疗效的当前研究结果的综合.
主要成果:
- 神经递质系统,特别是血清素,与PSD有关,选择性血清素再吸收抑制剂 (SSRI) 显示有效性.
- 其他因素,如神经炎症,神经内分泌学,神经营养因素和中风病变位置影响PSD的发展.
- 药理疗法包括SSRI,NaSSA,抗炎药物和维生素D在临床研究中已经证明有效.
结论:
- 虽然取得了进展,但PSD的确切机制仍然不完全理解.
- 目前的治疗方法有好处,但进一步的研究对于全面的预防和管理策略至关重要.
- 对PSD机制和治疗选择的持续调查对于改善患者的治疗结果至关重要.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
01:25Antidepressant Drugs: Overview
511
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
511
01:28Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
401
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
401
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
01:27Depressive Disorders: Etiology
103
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
103